Oxidative Medicine and Cellular Longevity · 2016 · 42 citations · 31 references
Life SciencesCancer BiologyPharmacologyCancer PharmacologyCellular MetabolismRedox BiochemistryAntioxidant DefenseOxidative Damage To BiomoleculesOxidative StressOxidative Stress MechanismsReactive Oxygen SpeciesRedox SignalingAntioxidantsCellular Antioxidant DefenseCellular Antioxidant ResponseCellular Oxidative Stress ResponseGlutathione Peroxidase ActivityGlutathione SystemPhosphatidylinositol 3-Kinase-akt PathwayPi3k-akt Signaling Pathway
Reactive oxygen species (ROS) play an important role in multidrug resistance (MDR). This study aimed to investigate the effects of long‐term ROS alteration on MDR in MCF‐7 cells and to explore its underlying mechanism. Our study showed both long‐term treatments of H 2 O 2 and glutathione (GSH) led to MDR with suppressed iROS levels in MCF‐7 cells. Moreover, the MDR cells induced by 0.1 μ M H 2 O 2 treatment for 20 weeks (MCF‐7/ROS cells) had a higher viability and proliferative ability than the control MCF‐7 cells. MCF‐7/ROS cells also showed higher activity or content of intracellular antioxidants like glutathione peroxidase (GPx), GSH, superoxide dismutase (SOD), and catalase (CAT). Importantly, MCF‐7/ROS cells were characterized by overexpression of MDR‐related protein 1 (MRP1) and P‐glycoprotein (P‐gp), as well as their regulators NF‐E2‐related factor 2 (Nrf2), hypoxia‐inducible factor 1 (HIF‐1 α ), and the activation of PI3K/Akt pathway in upstream. Moreover, several typical MDR mediators, including glutathione S‐transferase‐ π (GST‐ π ) and c‐Myc and Protein Kinase C α (PKC α ), were also found to be upregulated in MCF‐7/ROS cells. Collectively, our results suggest that ROS may be critical in the generation of MDR, which may provide new insights into understanding of mechanisms of MDR.
31
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.
Katrina M. Comerford, Timothy J. Wallace, Jörn Karhausen et al. · PubMed · 2002 · 844 citations
Medicine, Oncology, Pharmacology +16